The Economic Burden Of Dasatinib And Nilotinib Treatment Failure In Chronic Myeloid Leukemia (Cml) Patients: A Real-World Analysis

Authors :: Shibani Pokras
Victoria Divino
Cheryl P Ferrufino
Arnold R.J.G.
Hui Huang
Source :: Value in Health. 16(3)
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Oncology
Dasatinib
medicine.medical_specialty
Nilotinib
business.industry
Internal medicine
Health Policy
medicine
Public Health, Environmental and Occupational Health
Myeloid leukemia
business
Treatment failure
medicine.drug

Full Text Access

Tools